中华行为医学与脑科学杂志
中華行為醫學與腦科學雜誌
중화행위의학여뇌과학잡지
CHINESE JOURNAL OF BEHAVIORAL MEDICINE AND BRAIN SCIENCE
2012年
9期
790-792
,共3页
张广芬%王楠%石金云%李晓敏%徐世霞%周志强%杨建军
張廣芬%王楠%石金雲%李曉敏%徐世霞%週誌彊%楊建軍
장엄분%왕남%석금운%리효민%서세하%주지강%양건군
氯胺酮%抑郁%L-精氨酸%一氧化氮
氯胺酮%抑鬱%L-精氨痠%一氧化氮
록알동%억욱%L-정안산%일양화담
Ketamine%Depression%L-arginine%Nitric oxide
目的 研究L-精氨酸/一氧化氮(NO)信号通路在氯胺酮抗抑郁中的作用.方法 雄性Wistar大鼠42只,200~250g,随机数字表法分为7组(n=6):对照组(C组)、L-精氨酸(NO合成前体物质)组(LA组)、L-NAME[非特异性一氧化氮合酶(NOS)抑制剂]组(LN组)、氯胺酮3.0 mg/kg组(K3组)、氯胺酮10 mg/kg组(K10组)、L-精氨酸+氯胺酮10.0 mg/kg组(LAK10组)、L-NAME+氯胺酮3.0 mg/kg组(LNK3组).强迫游泳15 min建立大鼠抑郁模型(前游泳),24h后再次强迫游泳实验6min(测试游泳),记录后5 min不动时间.在测试游泳前90 min各组大鼠分别给予生理盐水1.0ml、L-精氨酸75 mg/kg或L-NAME 30 mg/kg预处理.在测试游泳前60 min分别给予生理盐水1.0ml、氯胺酮3.0 mg/kg或氯胺酮10.0 mg/kg治疗.行为学测试结束后,取大鼠海马组织测定NO含量.结果 与C组相比[不动时间:(139.0±27.6)s],K10组、LNK3组不动时间明显下降[(85.5 ±34.2)s,(91.3 ±31.6)s] (P<0.05),K3组、LA组、LAK10组、LN组未见显著差异(P>0.05);与C组相比[(0.61 ±0.21) μmol/gProt],LA组显著上升[( 1.09 ±0.39) μmol/gProt] (P< 0.05),K10组、LNK3组NO含量显著下降[(0.28±0.12) μmol/gProt,(0.31±0.14) μmol/gProt](P<0.05),K3组、LAK10组、LN组间差异无统计学意义(P>0.05).结论 氯胺酮的抗抑郁作用与海马L-精氨酸/一氧化氮信号通路抑制有关.
目的 研究L-精氨痠/一氧化氮(NO)信號通路在氯胺酮抗抑鬱中的作用.方法 雄性Wistar大鼠42隻,200~250g,隨機數字錶法分為7組(n=6):對照組(C組)、L-精氨痠(NO閤成前體物質)組(LA組)、L-NAME[非特異性一氧化氮閤酶(NOS)抑製劑]組(LN組)、氯胺酮3.0 mg/kg組(K3組)、氯胺酮10 mg/kg組(K10組)、L-精氨痠+氯胺酮10.0 mg/kg組(LAK10組)、L-NAME+氯胺酮3.0 mg/kg組(LNK3組).彊迫遊泳15 min建立大鼠抑鬱模型(前遊泳),24h後再次彊迫遊泳實驗6min(測試遊泳),記錄後5 min不動時間.在測試遊泳前90 min各組大鼠分彆給予生理鹽水1.0ml、L-精氨痠75 mg/kg或L-NAME 30 mg/kg預處理.在測試遊泳前60 min分彆給予生理鹽水1.0ml、氯胺酮3.0 mg/kg或氯胺酮10.0 mg/kg治療.行為學測試結束後,取大鼠海馬組織測定NO含量.結果 與C組相比[不動時間:(139.0±27.6)s],K10組、LNK3組不動時間明顯下降[(85.5 ±34.2)s,(91.3 ±31.6)s] (P<0.05),K3組、LA組、LAK10組、LN組未見顯著差異(P>0.05);與C組相比[(0.61 ±0.21) μmol/gProt],LA組顯著上升[( 1.09 ±0.39) μmol/gProt] (P< 0.05),K10組、LNK3組NO含量顯著下降[(0.28±0.12) μmol/gProt,(0.31±0.14) μmol/gProt](P<0.05),K3組、LAK10組、LN組間差異無統計學意義(P>0.05).結論 氯胺酮的抗抑鬱作用與海馬L-精氨痠/一氧化氮信號通路抑製有關.
목적 연구L-정안산/일양화담(NO)신호통로재록알동항억욱중적작용.방법 웅성Wistar대서42지,200~250g,수궤수자표법분위7조(n=6):대조조(C조)、L-정안산(NO합성전체물질)조(LA조)、L-NAME[비특이성일양화담합매(NOS)억제제]조(LN조)、록알동3.0 mg/kg조(K3조)、록알동10 mg/kg조(K10조)、L-정안산+록알동10.0 mg/kg조(LAK10조)、L-NAME+록알동3.0 mg/kg조(LNK3조).강박유영15 min건립대서억욱모형(전유영),24h후재차강박유영실험6min(측시유영),기록후5 min불동시간.재측시유영전90 min각조대서분별급여생리염수1.0ml、L-정안산75 mg/kg혹L-NAME 30 mg/kg예처리.재측시유영전60 min분별급여생리염수1.0ml、록알동3.0 mg/kg혹록알동10.0 mg/kg치료.행위학측시결속후,취대서해마조직측정NO함량.결과 여C조상비[불동시간:(139.0±27.6)s],K10조、LNK3조불동시간명현하강[(85.5 ±34.2)s,(91.3 ±31.6)s] (P<0.05),K3조、LA조、LAK10조、LN조미견현저차이(P>0.05);여C조상비[(0.61 ±0.21) μmol/gProt],LA조현저상승[( 1.09 ±0.39) μmol/gProt] (P< 0.05),K10조、LNK3조NO함량현저하강[(0.28±0.12) μmol/gProt,(0.31±0.14) μmol/gProt](P<0.05),K3조、LAK10조、LN조간차이무통계학의의(P>0.05).결론 록알동적항억욱작용여해마L-정안산/일양화담신호통로억제유관.
Objective To study the role of L-arginine/nitric oxide (NO) pathway in the antidepressant effects of ketamine.Methods Forty two male Wistar rats (200-250 g) were equally randomized into 7 groups ( n =6 ):control group ( C group ),L-Arginine ( a precursor of NO ) group ( LA group),L-NAME ( an non-selectivity inhibitor of NO synthase) group ( LN group),ketamine 3 mg/kg group ( K3 group),ketamine 10 mg/kg group (K10 group),L-Arginine + ketamine 10 mg/kg group(LAK10 group),L-NAME + ketamine 3 mg/kg group (LNK3 group).The forced swimming test (FST) of 15 min (pre-test session) was used to establish a rat depression model,then twenty-four hours later FST (test session) was carried out of 6 min and the immobility time in last 5 min was recorded. All the groups were pretreated with saline 1.0 ml,L-arginine 750 mg/kg or L-NAME 30 mg/kg 90 min before FST.Saline 1.0 ml,ketamine 3.0 mg/kg or ketamine 10.0 mg/kg were injected 60 min before FST.The content of hippocampal NO was detected immediately after ethology measurement.Results Compared with C group (immobility time:( 139.0 ± 27.6)s),the immobility time decreased significantly (( 85.5 ± 34.2),(91.3 ±31.6)s) in K10 group and LNK3 group (P<0.05),K3 group,LA group,LAK10 group and LN group had no significant difference (P>0.05) ;compared with C group ( (0.61 ±0.21 ) μmol/gProt),the content of NO increased in LA group ( ( 1.09 ±0.39) μmol/gProt) and decreased in K10 group and LNK3 group significantly( (0.28 ± 0.12),(0.31 ± 0.14 ) μmol/gProt) (P < 0.05 ),K3 group,LAK10 group and LN group had no significant difference (P > 0.05).Conclusion The antidepressant effects of ketamine are related to the suppression of L-arginine/nitric oxide pathway.